Denmark· DK-28106603221

Serefarm

A salmeterol and fluticasone product containing fluticasonpropionat, salmeterolxinafoat, registered in Denmark by Orifarm Generics A/S. The same ATC class is registered in 14 of our 19 countries.

ATC R03AK06

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedSerefarmATCR03AK06REGISTER NO.DK-28106603221PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Salmeterol and fluticasone is registered in 14 of 19 countries.

Countries holding a registration under ATC R03AK06 (salmeterol and fluticasone), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 9 of them publish a price we can compare per daily dose

Salmeterol and fluticasone · ATC R03AK06

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
FLUTICASONPROPIONAT, SALMETEROLXINAFOAT
Manufacturer
Orifarm Generics A/S
Country
Denmark (DK)
ATC code
R03AK06
ATC class
Salmeterol and fluticasone
Defined daily dose
0.1 mg, Inhal
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106603221

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

718 interactions on record for salmeterol and fluticasone.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Salmeterol and fluticasone · interactions on record

718 records

  • 49 severe
  • 397 moderate
  • 24 minor
  • 248 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • PindololC07AA03severe
  • PropranololC07AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce5466df-c974-4ca0-bfb9-a2909c851c54
GET /v1/drugs/ce5466df-c974-4ca0-bfb9-a2909c851c54?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "inhalationspulver, afdelt",
  "source": "dkma",
  "strength": "50+250 mikrog./dosis",
  "auth_role": "CMS",
  "dk_drugid": "28106603221",
  "substance": "FLUTICASONPROPIONAT, SALMETEROLXINAFOAT",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "44749"
}

See everything about salmeterol and fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.